Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 0 | 0 | 0 | 0 |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | 15.6M | 8.8M | 10.8M | 6.9M |
| Selling general and admin | 4.1M | 3.8M | 4.7M | 4.1M |
| Other operating expenses | — | — | — | — |
| Operating income | -19.8M | -12.6M | -15.5M | -11.0M |
| Non operating interest income | ||||
| Income | 1.7M | 3.6M | 1.2M | 906K |
| Expense | 0 | 0 | 381K | 652K |
| Other income expense | 1.1M | -479K | 914K | 737K |
| Pretax income | -17.0M | -9.5M | -13.8M | -10.0M |
| Tax provision | — | — | — | — |
| Net income | -17.0M | -9.5M | -13.8M | -10.0M |
| Basic EPS | -1.4 | -0.8 | -1.2 | -0.9 |
| Diluted EPS | -1.4 | -0.8 | -1.2 | -0.9 |
| Basic average shares | 12.2M | 12.2M | 12.0M | 11.1M |
| Diluted average shares | 12.2M | 12.2M | 12.0M | 11.1M |
| EBITDA | -16.9M | -9.4M | -13.5M | -9.2M |
| Net income from continuing op. | -17.0M | -9.5M | -13.8M | -10.0M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |